TriLink, Alphazyme Launch Novel RNA Polymerase for Production
24 Sep 2024 //
CONTRACTPHARMA
TriLink & Alphazyme Launch CleanScribe™ RNA Polymerase
24 Sep 2024 //
BUSINESSWIRE
Cygnus And TriLink Launch AccuRes™ Host Cell DNA Quantification Kits
28 Aug 2024 //
BUSINESSWIRE
TriLink, Johns Hopkins Establish New RNA Innovation Center
13 May 2024 //
BUSINESSWIRE
TriLink Invests in New RNA Innovation Center at Johns Hopkins
13 May 2024 //
CONTRACT PHARMA
TriLink, Lonza In License Deal For CleanCap® mRNA Technology
30 Apr 2024 //
BUSINESSWIRE
TriLink BioTech Announces New San Diego Facility For mRNA Drug Production
18 Apr 2024 //
BUSINESSWIRE
TriLink Solidifies IP Position with Awarded Patents for CleanCap Technology
21 Feb 2024 //
PRESS RELEASE
TriLink Solidifies IP Position with Awarded Patents for CleanCap
21 Feb 2024 //
BUSINESSWIRE
TriLink set to expand mRNA manufacturing facility
25 May 2023 //
FIERCE PHARMA
TriLink BioTechnologies® Announces Manufacturing Capabilities Expansion
24 May 2023 //
BUSINESSWIRE
TriLink BioTechnologies Introduces Latest mRNA Capping Technology
09 May 2023 //
GLOBENEWSWIRE
TriLink BioTechnologies Unveils Latest mRNA Capping Technology
09 May 2023 //
CONTRACT PHARMA
TriLink BioTechnologies Introduces Latest mRNA Capping Technology: CleanCap® M6 analog
09 May 2023 //
PRESS RELEASE
Genezen Appoints Jeff Whitmore as Chief Commercial Officer
29 Nov 2022 //
CONTRACTPHARMA
TriLink BioTechnologies, Part of Maravai LifeSciences, Expands its Mrna
13 Sep 2022 //
GLOBENEWSWIRE
TriLink Bio, part of Maravai LifeSciences, Expands R&D Leadership Team
06 Jul 2022 //
GLOBENEWSWIRE
TriLink BioTech Announces Cooperative Agreement With Department of Defense
24 May 2022 //
GLOBENEWSWIRE
TriLink Extends EyeGene Partnership for COVID-19 Vaccine Development
05 Oct 2021 //
CONTRACTPHARMA
TriLink BioTechnologies® Extends Global Support of Covid-19 Vaccine
02 Aug 2021 //
GLOBENEWSWIRE
Maravai Expands CDMO Capabilities Through TriLink Biotechnologies
15 Mar 2021 //
CONTRACTPHARMA